If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX(1-800-545-5979)
Humalog®
- Full Prescribing Information
Humalog® U-100 (insulin lispro injection)
100 units/mL - Full Prescribing Information
Humalog® U-200 (insulin lispro injection)
200 units/mL - Full Prescribing Information
Humalog® MIX50/50™ (50% insulin lispro protamine suspension 50% insulin lispro injection [rDNA origin])
100 units/mL - Full Prescribing Information
Humalog® MIX75/25™ (75% insulin lispro protamine suspension 25% insulin lispro injection [rDNA origin])
100 units/mL
This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
HUMALOG® (insulin lispro): Changing From Other Mealtime Insulin Products
Dose adjustment may be needed when transitioning from another insulin to Humalog.
Dose adjustment may be needed when transitioning from another insulin to IL-100.1
The patient's GC or predisposition to hypoglycemia or hyperglycemia may be affected by changes in insulin
-
strength
-
manufacturer
-
type
-
injection site, or
-
method of administration.1
Any changes to insulin regimen for a patient with DM should be made cautiously and under close medical supervision and the frequency of BG monitoring should be increased.1
Enclosed Prescribing Information
HUMALOG® (insulin lispro injection), for subcutaneous or intravenous use, Lilly
1. Humalog [package insert]. Indianapolis, IN: Eli Lilly and Company; 2019.
Glossary
BG = blood glucose
DM = diabetes mellitus
GC = glucose control
IL-100 = Humalog® (insulin lispro injection) 100 units/mL
Date of Last Review: December 13, 2019
Contact Lilly
Call Us
If you need information about a Lilly product or want to report an Adverse Event or Product Complaint, you may call us.
Available Mon – Friday, 9am-7pm (EST), excluding holidays